Buyers Accumulate Shares of Halozyme Therapeutics, Up 19.4%
Halozyme Therapeutics (NASDAQ:HALO) is one of today's notable stocks on the rise, up 19.4% to $6.59. The S&P is trading lower by 1.0% to 1,429 and the Dow is trading 0.9% lower to 13,193.
Halozyme Therapeutics is in SmarTrend's Biotechnology industry and this industry is currently in an Uptrend according to our research. We are monitoring many other stocks on the move within this industry.
Over the past year, Halozyme Therapeutics has traded in a range of $3.86 to $13.50 and is now at $6.59, 71% above that low. In the last five trading sessions, the 50-day moving average (MA) has fallen 3.1% while the 200-day MA has slid 1.9%.
SmarTrend recommended that its subscribers protect gains by selling shares of Halozyme Therapeutics on October 22nd, 2012 by issuing a Downtrend alert when the shares were trading at $5.71. Since that call, shares of Halozyme Therapeutics have fallen 3.2%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.
Keywords: market movers halozyme therapeutics